Ionic liquid-derived blood-compatible composite membranes for kidney dialysis.

A novel heparin- and cellulose-based biocomposite is fabricated by exploiting the enhanced dissolution of polysaccharides in room temperature ionic liquids (RTILs). This represents the first reported example of using a new class of solvents, RTILs, to fabricate blood-compatible biomaterials. Using this approach, it is possible to fabricate the biomaterials in any form, such as films or membranes, fibers (nanometer- or micron-sized), spheres (nanometer- or micron-sized), or any shape using templates. In this work, we have evaluated a membrane film of this composite. Surface morphological studies on this biocomposite film showed the uniformly distributed presence of heparin throughout the cellulose matrix. Activated partial thromboplastin time and thromboelastography demonstrate that this composite is superior to other existing heparinized biomaterials in preventing clot formation in human blood plasma and in human whole blood. Membranes made of these composites allow the passage of urea while retaining albumin, representing a promising blood-compatible biomaterial for renal dialysis, with a possibility of eliminating the systemic administration of heparin to the patients undergoing renal dialysis.

[1]  M. Sobel,et al.  Development of heparin antagonists with focused biological activity. , 1999, Current pharmaceutical design.

[2]  A. Denizli.  Heparin-immobilized poly(2-hydroxyethylmethacrylate)-based microspheres , 1999 .

[3]  R. Sheldon.  Catalytic reactions in ionic liquids. , 2001, Chemical communications.

[4]  G. Campbell,et al.  Preparation and characterization of a poly(2-hydroxyethyl methacrylate) biomedical hydrogel , 2001 .

[5]  T. Ortel,et al.  HEPARIN‐INDUCED THROMBOCYTOPENIA IN DIALYSIS: Alternative Methods of Anticoagulation for Dialysis‐dependent Patients with Heparin‐induced Thrombocytopenia , 2003 .

[6]  Robert Langer,et al.  Zero-order release of micro- and macromolecules from polymeric devices: the role of the burst effect , 1997 .

[7]  V. Nielsen.  The Detection of Changes in Heparin Activity in the Rabbit: A Comparison of Anti-Xa Activity, Thrombelastography®, Activated Partial Thromboplastin Time, and Activated Coagulation Time , 2002, Anesthesia and analgesia.

[8]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.

[9]  R. Nicholas,et al.  Low-molecular-weight heparin in preventing and treating DVT. , 1999, American family physician.

[10]  R. Sheldon.  Catalytic Reactions in Ionic Liquids , 2002 .

[11]  M. Hendriks,et al.  Covalently-Bound Heparin Makes Collagen Thromboresistant , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Risbud,et al.  Suitability of cellulose molecular dialysis membrane for bioartificial pancreas: in vitro biocompatibility studies. , 2001, Journal of biomedical materials research.

[13]  R. Linhardt,et al.  Benzoate-based room temperature ionic liquids—thermal properties and glycosaminoglycan dissolution , 2006 .

[14]  R. Linhardt,et al.  Dialkyl Imidazolium Benzoates - Room Temperature Ionic Liquids Useful in the Peracetylation and Perbenzoylation of Simple and Sulfated Saccharides , 2003 .

[15]  Brian J. Tighe,et al.  A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies , 1998 .

[16]  R. Langer,et al.  An enzymatic system for removing heparin in extracorporeal therapy. , 1982, Science.

[17]  P. Rieu,et al.  New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  A. Piozzi,et al.  Covalent bonding of heparin to a vinyl copolymer for biomedical applications. , 1997, Biomaterials.

[19]  G. Elgue,et al.  Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin. , 1998, Thrombosis research.

[20]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[21]  K. Seddon,et al.  Ionic liquids: designer solvents for green synthesis , 2002 .

[22]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[23]  Y Noishiki,et al.  Tissue biocompatibility of cellulose and its derivatives. , 1989, Journal of biomedical materials research.

[24]  Ziniu Yu,et al.  Dissolution of cellulose with ionic liquids and its application : a mini-review , 2006 .

[25]  W-C. Lin,et al.  Surface Modification and Blood Compatibility of Polyacrylonitrile Membrane with Immobilized Chitosan–Heparin Conjugate , 2002 .

[26]  B. Jaber,et al.  Hemodialysis in Acute Renal Failure: Does the Membrane Matter? , 2001, Seminars in dialysis.

[27]  Y. M. Lee,et al.  Preparation and surface characterization of functional group-grafted and heparin-immobilized polyurethanes by plasma glow discharge. , 1996, Biomaterials.

[28]  Ting-yu Liu,et al.  Hemocompatibility of polyacrylonitrile dialysis membrane immobilized with chitosan and heparin conjugate. , 2004, Biomaterials.

[29]  Robin D. Rogers,et al.  Dissolution of Cellose with Ionic Liquids , 2002 .

[30]  R. Breiterman-White.  A review of heparin use in hemodialysis and peritoneal dialysis. , 1995, ANNA journal.

[31]  T. Ortel,et al.  Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. , 2003, Seminars in dialysis.

[32]  G. Lyons,et al.  In vitro evidence of gender-related heparin resistance. , 2004, International journal of obstetric anesthesia.

[33]  R. Linhardt,et al.  Ionic Liquids in Carbohydrate Chemistry - Current Trends and Future Directions , 2005 .